The growing demand for specific immunological research and therapeutic creation has spurred significant improvements in recombinant signal molecule manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using multiple expression methods, including prokaryotic hosts, higher cell cultures, and